The insatiable demand for weight loss and diabetes drugs is still trouncing supply, even as Eli Lilly and Novo Nordisk work to increase production capacity.
Source: https://www.cnbc.com/2024/04/17/eli-lil ... says-.html
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
